Corrigendum to "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)" [Clin. Neurophysiol. 131 (2020) 474-528]

Jean-Pascal Lefaucheur, André Aleman, Chris Baeken, David H Benninger, Jérôme Brunelin, Vincenzo Di Lazzaro, Saša R Filipović, Christian Grefkes, Alkomiet Hasan, Friedhelm C Hummel, Satu K Jääskeläinen, Berthold Langguth, Letizia Leocani, Alain Londero, Raffaele Nardone, Jean-Paul Nguyen, Thomas Nyffeler, Albino J Oliveira-Maia, Antonio Oliviero, Frank PadbergUlrich Palm, Walter Paulus, Emmanuel Poulet, Angelo Quartarone, Fady Rachid, Irena Rektorová, Simone Rossi, Hanna Sahlsten, Martin Schecklmann, David Szekely, Ulf Ziemann

Research output: Contribution to journalComment/debate

10 Citations (Scopus)

Abstract

When referring to the study of Rutherford et al. (2015) on short- and long-term effects of rTMS in Alzheimer's disease, we erroneously stated in our article (Lefaucheur et al., 2020) that a clinical benefit on cognitive performance (tested by the Montreal Cognitive Assessment) was observed at weeks 2–3, only in the real stimulation condition during an initial sham-controlled 4-week period of treatment, and that then this benefit was prolonged by “2 additional weeks” of open-label real rTMS. In fact, this extended open-label treatment was administered for up to 19 months in multiple 2-week blocks with 2–7 months intervals between blocks and was not limited to a single additional 2-week block of treatment immediately following the original 4 weeks of treatment. Therefore, the results of that open-label extended follow-up study support the value of long-term maintenance treatment using multiple rTMS sessions rather than be interpreted as short-term 2-week extension.

Original languageEnglish
Pages (from-to)1168-1169
Number of pages2
JournalClinical Neurophysiology
Volume131
Issue number5
Early online date19 Feb 2020
DOIs
Publication statusPublished - May 2020

Keywords

  • rTMS
  • therapeutic use

Fingerprint Dive into the research topics of 'Corrigendum to "Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)" [Clin. Neurophysiol. 131 (2020) 474-528]'. Together they form a unique fingerprint.

Cite this